Novo Nordisk's banner

Novo Nordisk

@novonordisk • 57,082 subscribers

We're dedicated to championing long-term health. Stay tuned for news and the latest in innovation 💙 Community guide 👇

Shorts

Medicamentos manipulados com semaglutida biológica são proibidos pela Anvisa.

Medicamentos manipulados com semaglutida biológica são proibidos pela Anvisa.

13,998,769 görüntüleme

#PRESS Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

#PRESS Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

15,438 görüntüleme

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered. Read more here:

Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered. Read more here:

138,125 görüntüleme • 2 ay önce

#PRESS: Our quarterly results are out! We're off to a good start to 2026 with exciting momentum across our pipeline. Hear our CEO Mike Doustdar reflect on our results - and read more in the company announcement here:

#PRESS: Our quarterly results are out! We're off to a good start to 2026 with exciting momentum across our pipeline. Hear our CEO Mike Doustdar reflect on our results - and read more in the company announcement here:

47,413 görüntüleme • 1 ay önce

#PRESS: Our 2025 full-year results and 2026 outlook are out. Learn more in the company announcement here:

#PRESS: Our 2025 full-year results and 2026 outlook are out. Learn more in the company announcement here:

44,765 görüntüleme • 4 ay önce

#PRESS Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

#PRESS Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

46,696 görüntüleme • 7 ay önce

#PRESS: Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025

#PRESS: Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025

15,681 görüntüleme • 10 ay önce

#PRESS Novo Nordisk's sales increased by 25% in Danish kroner and by 26% at constant exchange rates to DKK 290.4 billion in 2024

#PRESS Novo Nordisk's sales increased by 25% in Danish kroner and by 26% at constant exchange rates to DKK 290.4 billion in 2024

14,300 görüntüleme • 1 yıl önce

Daha fazla içerik yok.